Computational research and data science are revolutionizing the field of medicine. ZIB covers a broad range of activities such as the development of novel methods for enabling the simulation and prediction of drug interactions, allowing for more efficient and targeted drug design processes, or of the design of new techniques for analyzing vast amounts of biological and clinical data to uncover patterns, predict disease outcomes, and identify potential drug targets. Furthermore, our researchers are involved in the development of personalized medicine by integrating patient-specific data to tailor treatments, optimize healthcare outcomes, and enhance overall patient care in the realm of digital health.